CIK: 1385115 - Address: Oppenheimer 4, Rehovot, L3 7670104
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-0-1922422416
S%wins63632538635050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/4/12 17:13
5/2/12
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.d-8987.1311-126-1000I03912138-6-310-11-17-27-22
10/8/10 16:10
10/7/10
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.d-6779.675-70-1000I350949542916167-4-5310-32-50
9/8/10 16:34
9/3/10
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.dm-5658.073-70-1000I26711152724138705168-23-44
10/19/09 20:42
10/15/09
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.dm-1,4199.465-150-1000I-7137026167251337-3-1117-24-305
7/8/09 17:00
7/6/09
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.dm-2555.112-50-1000I-838716210935241952842694830
5/19/09 19:01
5/18/09
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.d-1204.000-30-1000I-8633146466040168-2-676618069
3/13/09 19:18
3/11/09
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagMaimon YossiL3OVP,CFOS.dm-1092.240-49-1000I-90-26-542-13-152-2081171240219
2/26/08 17:20
2/25/08
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagYossi MaimonL3OVP,CFOS.d-1063.180-33-5627I-92-84-93-2712-43-14-6-16-9-24-17

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact